Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Aimo

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Tumori|November 1, 1996
Preliminary results of clinical evaluation of the free/total prostate-specific antigen ratio in a multicentric studyR Mione, G Aimo, E Bombardieri, et al.
Clinical Chemistry|December 4, 1998
Percent free prostate-specific antigen in assessing the probability of prostate cancer under optimal analytical conditionsM Gion, R Mione, P Barioli, et al.
The International Journal of Biological Markers|November 6, 1998
Prostate cancer probability after total PSA and percent free PSA determinationR Mione, P Barioli, M Barichello, et al.
European Urology|April 15, 2000
Clinical evaluation of percent free prostate-specific antigen using the AxSYM system in the best analytical scenarioM Gion, R Mione, P Barioli, et al.
Journal of the Neurological Sciences|March 4, 1999
Autoimmune events during interferon beta-1b treatment for multiple sclerosisL Durelli, B Ferrero, A Oggero, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Tumori|November 1, 1996
Preliminary results of clinical evaluation of the free/total prostate-specific antigen ratio in a multicentric studyR Mione, G Aimo, E Bombardieri, et al.
Clinical Chemistry|December 4, 1998
Percent free prostate-specific antigen in assessing the probability of prostate cancer under optimal analytical conditionsM Gion, R Mione, P Barioli, et al.
The International Journal of Biological Markers|November 6, 1998
Prostate cancer probability after total PSA and percent free PSA determinationR Mione, P Barioli, M Barichello, et al.
European Urology|April 15, 2000
Clinical evaluation of percent free prostate-specific antigen using the AxSYM system in the best analytical scenarioM Gion, R Mione, P Barioli, et al.
Journal of the Neurological Sciences|March 4, 1999
Autoimmune events during interferon beta-1b treatment for multiple sclerosisL Durelli, B Ferrero, A Oggero, et al.
Pageof 5